Combined intravenous and intraarterial tissue plasminogen activator for acute ischemic stroke: Recanalization, safety, and early clinical outcome

被引：0
|
作者：
Saver, JL
Kidwell, CS
Starkman, S
Carneado, J
Jahan, R
Gobin, YP
Duckwiler, GR
Vespa, PM
Villablanca, JP
Vinuela, F
机构：
来源：
NEUROLOGY | 2001年 / 56卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A150 / A150
页数：1
相关论文
共 50 条
  • [1] Combined intravenous/intraarterial compared with Intraarterial recombinant tissue plasminogen activator in acute ischemic stroke: Propensity score analysis
    Zaidat, OO
    Welter, E
    Love, TE
    Tarr, RW
    Sunshine, JL
    Landis, DMD
    Selman, WR
    Enterline, DS
    Smith, TP
    Alexander, MJ
    JOURNAL OF NEUROSURGERY, 2004, 100 (01) : A181 - A181
  • [2] Safety and efficacy of intravenous tissue plasminogen activator in acute ischemic stroke
    Rajapa, S.
    Sivakumar, S.
    Arjundas, D.
    INTERNATIONAL JOURNAL OF STROKE, 2015, 10 : 133 - 133
  • [3] Hemorrhage, Recanalization, and Clinical Outcomes for Combined Intravenous and Intraarterial Thrombolysis for Acute Ischemic Stroke
    Janjua, Nazli
    Melkumova, Emiliya
    Akrem, Shamrez
    Hussein, Haitham
    Ramirez-Abreu, Darwin
    Poleshuck, Rebecca
    McIntyre, Sherene
    Gropen, Toby
    Morales, Ximena
    Qureshi, Adnan
    NEUROLOGY, 2011, 76 (09) : A152 - A152
  • [4] Time to Treatment With Intravenous Tissue Plasminogen Activator and Outcome From Acute Ischemic Stroke
    Saver, Jeffrey L.
    Fonarow, Gregg C.
    Smith, Eric E.
    Reeves, Mathew J.
    Grau-Sepulveda, Maria V.
    Pan, Wenqin
    Olson, DaiWai M.
    Hernandez, Adrian F.
    Peterson, Eric D.
    Schwamm, Lee H.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 309 (23): : 2480 - 2488
  • [5] Utilization of intravenous tissue plasminogen activator for acute ischemic stroke
    Katzan, IL
    Hammer, MD
    Hixson, ED
    Furlan, AJ
    Abou-Chebl, A
    Nadzam, DM
    ARCHIVES OF NEUROLOGY, 2004, 61 (03) : 346 - 350
  • [6] Intravenous recombinant tissue plasminogen activator for acute ischemic stroke: a feasibility and safety study
    Sadeghi-Hokmabadi, Elyar
    Farhoudi, Mehdi
    Taheraghdam, Aliakbar
    Hashemilar, Mazyar
    Savadi-Osguei, Daryous
    Rikhtegar, Reza
    Mehrvar, Kaveh
    Sharifipour, Ehsan
    Youhanaee, Parisa
    Mirnour, Reshad
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2016, 9 : 361 - 367
  • [7] Intravenous tissue plasminogen activator for acute ischemic stroke: Feasibility, safety, and efficacy in the first year of clinical practice
    Chiu, D
    Krieger, D
    Villar-Cordova, C
    Kasner, SE
    Morgenstern, B
    Bratina, PL
    Yatsu, FM
    Grotta, JC
    STROKE, 1998, 29 (01) : 303 - 303
  • [8] Acute Ischemic Stroke Treated with Intravenous Tissue Plasminogen Activator in a Patient Taking Dabigatran with Radiographic Evidence of Recanalization
    Sangha, Navdeep
    El Khoury, Ramy
    Misra, Vivek
    Lopez, George
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2012, 21 (08):
  • [9] Combined intravenous and intra-arterial recombinant tissue plasminogen activator in acute ischemic stroke
    Ernst, R
    Pancioli, A
    Tomsick, T
    Kissela, B
    Woo, D
    Kanter, D
    Jauch, E
    Carrozzella, J
    Spilker, J
    Broderick, J
    STROKE, 2000, 31 (11) : 2552 - 2557
  • [10] Acute ischemic stroke: improving access to intravenous tissue plasminogen activator
    Turner, Ashby C.
    Schwamm, Lee H.
    Etherton, Mark R.
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2020, 18 (05) : 277 - 287
12345